Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Multiple Sclerosis

Free Subscription 01.04.2024 1 Ann Neurol 1 BMC Neurol 1 Brain 6 J Neurol 2 J Neurol Neurosurg Psychiatry 3 Mult Scler 2 Neurology 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. ALPING P, Neovius M, Piehl F, Frisell T, et al
   Real-World Healthcare Cost Savings and Reduced Relapse Rate with Off-Label Rituximab versus Disease-Modifying Treatments Approved for Relapsing-Remitting Multiple Sclerosis: A Nationwide Cost-Effectiveness Study.
   Ann Neurol. 2024 Mar 26. doi: 10.1002/ana.26914.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. KURI A, Henshall DE, Chaudhry D, Ooi SZY, et al
   Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of Ireland.
   BMC Neurol. 2024;24:105.
   PubMed         Abstract available
   
   

   
   Brain

3. MAINERO C, Miscioscia A, Treaba CA
   Cortical remyelination in multiple sclerosis: a target for disease monitoring and intervention.
   Brain. 2024 Mar 27:awae083. doi: 10.1093.
   PubMed        
   
   

   
   J Neurol

4. GUILLEMIN C, Vandeleene N, Charonitis M, Requier F, et al
   Brain microstructure is linked to cognitive fatigue in early multiple sclerosis.
   J Neurol. 2024 Mar 28. doi: 10.1007/s00415-024-12316.
   PubMed         Abstract available
   
   
5. SCHALLER-PAULE MA, Maiworm M, Schafer JH, Friedauer L, et al
   Matching proposed clinical and MRI criteria of aggressive multiple sclerosis to serum and cerebrospinal fluid markers of neuroaxonal and glial injury.
   J Neurol. 2024 Mar 27. doi: 10.1007/s00415-024-12299.
   PubMed         Abstract available
   
   
6. MALLUCCI G, Ferraro OE, Trojano M, Amato MP, et al
   Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score.
   J Neurol. 2024 Mar 26. doi: 10.1007/s00415-024-12304.
   PubMed         Abstract available
   
   
7. PILOTTO S, Floris M, Solla P, Pugliatti M, et al
   Determinants of self-perceived quality of life in mildly disabled multiple sclerosis patients: a cross-sectional study.
   J Neurol. 2024 Mar 25. doi: 10.1007/s00415-024-12244.
   PubMed         Abstract available
   
   
8. GOERECI Y, Ellenberger D, Rommer P, Dunkl V, et al
   Persons with multiple sclerosis older than 55 years: an analysis from the German MS registry.
   J Neurol. 2024 Mar 22. doi: 10.1007/s00415-024-12286.
   PubMed         Abstract available
   
   
9. TEDONE N, Vizzino C, Meani A, Gallo A, et al
   The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI).
   J Neurol. 2024;271:1813-1823.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

10. KALINCIK T, Sharmin S, Roos I, Massey J, et al
    Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2024 Mar 27:jnnp-2023-332790.
    PubMed         Abstract available
    
    
11. VERSTEGEN NJM, Hagen RR, Kreher C, Kuijper LH, et al
    T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination.
    J Neurol Neurosurg Psychiatry. 2024 Mar 28:jnnp-2023-332224.
    PubMed         Abstract available
    
    

    
    Mult Scler

12. SIMPSON AC, Hu C, Mowry EM, Naismith RT, et al
    Structural MRI measures are associated with fatigue severity and persistence in a large, real-world cohort of people with multiple sclerosis.
    Mult Scler. 2024 Mar 25:13524585241239473. doi: 10.1177/13524585241239473.
    PubMed         Abstract available
    
    
13. SORENSEN PS, Bramow S, Magyari M, Werdelin L, et al
    Torben Fog - A Danish pioneer in a multi-faceted spectrum of multiple sclerosis research.
    Mult Scler. 2024 Mar 24:13524585241239506. doi: 10.1177/13524585241239506.
    PubMed         Abstract available
    
    
14. MAILLART E, Redolfi S, Louapre C, Houot M, et al
    Clinical correlates of respiratory disorders in patients with severe multiple sclerosis: A cross-sectional cohort.
    Mult Scler. 2024 Mar 22:13524585241238840. doi: 10.1177/13524585241238840.
    PubMed         Abstract available
    
    

    
    Neurology

15. 
    Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study.
    Neurology. 2024;102:e209214.
    PubMed        
    
    
16. PAPP V, Magyari M, Moller S, Sellebjerg F, et al
    Mortality of the Danish Nationwide AQP4 Antibody-Seropositive Neuromyelitis Optica Spectrum Disorder Patient Cohort.
    Neurology. 2024;102:e209147.
    PubMed         Abstract available
    
    

    
    PLoS One

17. CARATIS F, Opielka M, Hausmann M, Velasco-Estevez M, et al
    The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human and mouse oligodendrocytes: Exploring their role in neuroinflammation and multiple sclerosis.
    PLoS One. 2024;19:e0283060.
    PubMed         Abstract available
    
    
18. LEREIM RR, Nytrova P, Guldbrandsen A, Havrdova EK, et al
    Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
    PLoS One. 2024;19:e0300914.
    PubMed         Abstract available
    
    
19. BRNABIC AJM, Curtis SE, Johnston JA, Lo A, et al
    Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.
    PLoS One. 2024;19:e0300708.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.